相关实验视频
Updated: Jun 23, 2026

11:14
Acute Brain Trauma in Mice Followed By Longitudinal Two-photon Imaging
Published on: April 6, 2014
12.6K
向精子氧化酶以减轻老化大脑中创伤性脑损伤病理
Jui-Ming Sun1,2, Jing-Shiun Jan3, Ting-Lin Yen3,4
1Section of Neurosurgery, Department of Surgery, Ditmanson Medical Foundation, Chia-Yi Christian Hospital, Chia-Yi City 600, Taiwan.
Antioxidants (Basel, Switzerland)
|June 26, 2025
概括
精子氧化酶 (SMOX) 通过增加氧化应激和神经炎症来驱动与年龄相关的脑损伤脆弱性. 在老年小鼠中抑制SMOX改善了创伤性脑损伤 (TBI) 后的结果,这表明了一个新的治疗点.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生物化学
- 老年学是一门学科.
背景情况:
- 老龄化增加了对创伤性脑损伤 (TBI) 的易感性,导致更糟糕的结果.
- 与年龄相关的TBI脆弱性背后的机制,包括氧化应激和神经炎症,尚未完全理解.
研究的目的:
- 确定将衰老,氧化应激,神经炎症和TBI易感性联系在一起的分子机制.
- 调查精氨酸氧化酶 (SMOX) 在依赖年龄的TBI结局中的作用.
- 评估SMOX抑制作为老年人TBI的治疗策略.
主要方法:
- 利用受控皮质冲击 (CCI) 的小鼠模型来研究TBI.
- 评估了老年与年轻大脑中的SMOX表达,微质激活,细胞因子水平和神经元退化.
- 检查了星细胞谷氨酸转运器GLT-1的定位和功能.
- 分析了死后人类大脑样本和转录基因数据,以检测与年龄相关的SMOX变化.
- 在老年小鼠中使用JNJ-9350药理上抑制的SMOX,并评估了神经和行为结果.
主要成果:
- 在TBI后老老鼠大脑中,SMOX表达显著上调,特别是在神经元和微质中.
- 增加的SMOX与增加的微质激活,促炎性细胞因子和神经元退化相关.
- 通过GLT-1的干扰,SMOX的上调调节损害了通过GLT-1的星细胞谷氨酸清除,导致刺激毒性.
- 人类大脑数据证实了与年龄相关的SMOX增加,支持翻译相关性.
- 在老年小鼠中,SMOX抑制减少了氧化/炎症标志物,保留了神经元,并在TBI后改善了运动,认知和情绪功能.
结论:
- 斯莫克斯是与年龄相关的TBI脆弱性的关键调解者,它将氧化应激和神经炎症联系起来.
- 抑制SMOX是一种有希望的治疗方法,可以减轻老年人TBI的后果.
关键词:
老化的大脑老化大脑老化脑损伤治疗方法 脑损伤治疗方法神经炎症是一种神经炎症.神经元细胞死亡 神经元细胞死亡氧化应激是一种氧化应激.精氨酸氧化酶是一种精氨酸氧化酶.创伤性脑损伤是一种创伤性脑损伤更多相关视频
相关概念视频
Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Aging
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...

